Antiviral supplement formulations
The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
1. An antiviral supplement oral dosage form comprising a composition comprising a therapeutically effective amount of a lysine in a single dose range of from about 1,000 mg to about 5,000 mg, an ascorbic compound, a flavonoid glycoside comprising hesperidin and rutin, a threonine, a taurine and a pyridoxine.
2. The dosage form of claim 1 , wherein the dosage form is in a form selected from the group consisting of powder, capsule, lozenge, troche, tablet, liquid, and caplet.
3. The dosage form of claim 1 , wherein the dosage form is a solid dosage form.
4. The dosage form of claim 1 , wherein the dosage form is a chewable form.
5. The dosage form of claim 1 , wherein the dosage form is a divided dosage form, wherein one dose consists of a multiplicity of units of a solid, semi-solid, or lyophilized powder dosage form.
6. The dosage form of claim 1 , wherein the lysine is selected from L-lysine, L-lysine monohydrochloride, L-lysine dihydrochloride, L-lysine succinate, L-lysine glutamate, and L-lysine orotate.
7. The dosage form of claim 1 , wherein the ascorbic compound is selected from one or more of ascorbic acid, calcium ascorbate, magnesium ascorbate, potassium ascorbate, sodium ascorbate, manganese ascorbate, zinc ascorbate, iron ascorbate, copper ascorbate, boron ascorbate, molybdenum ascorbate, chromium ascorbate, ascorbyl palmitate, ascorbyl arachidonate, ascorbyl stearate, ascorbyllinoleate, ascorbyl linoleneate, and ascorbyl oleate.
8. The dosage form of claim 1 , wherein the flavonoid glycoside comprises hesperidin and rutin in a 1:1 weight ratio.
9. The dosage form of claim 1 , wherein the pyridoxine is pyridoxine hydrochloride.
10. The dosage form of claim 1 , wherein the composition comprises L-lysine monohydrochloride, ascorbic acid, hesperidin, rutin, threonine, taurine, and pyridoxine hydrochloride.
11. The dosage form of claim 10 , wherein the composition further comprising an additional ascorbic compound selected from the group consisting of calcium ascorbate, niacinamide ascorbate, and ascorbyl palmitate.
12. The dosage form of claim 1 , wherein the dosage form further comprises an additive selected from the group consisting of vehicle, binder, disintegrating agent, lubricant, thickener, surfactant, osmotic pressure regulator, electrolyte, sweetener, flavoring, perfume, pigment, and pH regulator.
13. The dosage form of claim 11 , wherein the disintegrating agent is selected from the group consisting of microcrystalline cellulose, carboxymethylcellulose (CMC), CMC-Na, CMC-Ca, and croscarmellose sodium.
14. The dosage form of claim 12 , wherein the lubricant is selected from the group consisting of leucine, isoleucine, valine, sugar-ester, hardening oil, stearic acid, magnesium stearate, talc, and macrogol.
15. The dosage form of claim 12 , wherein the sweetener is selected from the group consisting of glucose, fructose, maltose, sucrose, xylose, lactose, xylitol, sorbitol, mannitol, maltitol, xylitol, coupling sugar, paratinose, glycerin, erythritol, dextrin, cyclodextrin, fructo-oligosaccharide, galacto-oligosaccharide, lacto-sucrose, thaumatin, stevia, stevia extract, rebaudioside A, glycyrrhizinic acid, saccharin, alitame, and aspartame.
16. The dosage form of claim 1 , wherein a single dose comprises from about 2 g to about 3.5 g L-lysine monohydrochloride; from about 0.1 g to about 1.5 g ascorbic acid; from about 0.2 g to about 0.8 g hesperidin; from about 0.1 g to about 0.5 g rutin; from about 0.04 g to about 0.08 g pyridoxine hydrochloride; from about 0.01 g to about 0.08 g threonine; and from about 0.02 g to about 0.4 g taurine.
17. The dosage form of claim 16 , further comprising from about 0.5 g to about 0.75 g calcium ascorbate; from about 0.1 g to about 0.5 g niacinamide ascorbate; and from about 0.01 g to about 0.1 g ascorbyl palmitate.
18. The dosage form of claim 2 , wherein the dosage form is in a form of a tablet.
19. The dosage form of claim 18 , wherein the tablet is selected from an orally disintegrable form, chewable form, effervescent form, slow release form, or immediate release form.
20. The dosage form of claim 18 , wherein the tablet comprises L-lysine monohydrochloride, ascorbic acid, hesperidin, rutin, threonine, taurine, and pyridoxine hydrochloride.
21. The dosage form of claim 2 , wherein the dosage form is in a form of a capsule.